Sugi Predict

Sugi Predict / Compounds / SCHEMBL4476805

SCHEMBL4476805

SCHEMBL4476805

N#Cc1c(Nc2ccc(C(=O)NC3CCOC3=O)cc2)sc(C(=O)c2coc3ccccc23)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.46
▸ ALDH1A1 P00352 6/20 0.46
▸ GAA P10253 1/20 0.46
▸ POLB P06746 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ DRD2 P14416 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ MAOB P27338 2/20 0.35
▸ MELK Q14680 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MITF O75030 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13711684 0.91 MAOB (0.38) MAPTALDH1A1DRD2HTR2ADRD3
SCHEMBL4474220 0.87 MAPT (0.46) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4468052 0.86 MAPT (0.48) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4471831 0.82 MAPT (0.48) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4477182 0.82 MAPT (0.51) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4472094 0.81 MAPT (0.51) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4475799 0.81 ALDH1A1 (0.47) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4468120 0.80 MAPT (0.45) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4469147 0.80 ALDH1A1 (0.44) MAPTALDH1A1GAAPOLBHPGD
SCHEMBL4464981 0.79 MAPT (0.47) MAPTALDH1A1GAAPOLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A MAPT 3524/4885ALDH1A1 802/4885GAA 77/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A MAPT 3524/4885ALDH1A1 802/4885GAA 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.